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WS16.1 Energy expenditure during a session of physiotherapy in
CF patients
C. Opdekamp1, V. Sterckx1, F. Lessire2, A. Van Muylem1, H. Franckx2,
C. Knoop1. 1Erasme University Hospital, Adult Cystic Fibrosis Reference
Centre, Chest Medicine, Brussels, Belgium; 2Cystic Fibrosis Revalidation Centre,
Zeepreventorium, De Haan, Belgium
Background: Combined aerosoltherapy and bronchial drainage are key elements
of CF care. During bronchial drainage, the cough manoeuvres must be the most
effective and the least tiring.
Objectives: Our study aimed (1) to measure the resting energy expenditure (EE) in
CF patients compared to healthy subjects and (2) to verify the hypothesis that the
intensity of cough is a major constituent of the EE during a session of physiotherapy.
Population: Stable CF patients: 7 F/15 M; 32±6 yrs; BMI 19.9±3.3 kg/m2;
FEV1: 46.0±26.6% of predicted. Healthy subjects: 4 F/9 M; 29±6 yrs; BMI:
23.65±1.65 kg/m2.
Methods: EE (expressed in energy expenditure units [METs, kcal/kg/h]) was
estimated with an accelerometer (SenseWear Armband®). For the patients, EE
was measured during: (1) 15′ of rest (Rest1); (2) 15′ of nebulized therapy (Neb);
(3) 30′ of bronchial drainage (Physio); (4) 15′ of rest (Rest2). For healthy subjects,
EE was measured during Rest1 and Neb.
Results: The EE of patients vs. healthy subjects were 1.23±0.19 (0.92–1.58) vs.
0.96±0.04 (0.89–1.01) (p< 0.001); and 1.54±0.5 (0.96–3.04) vs. 0.96±0.05 (0.90–
1.09) (p< 0.001) for Rest1 and Neb, respectively. EE was 1.86±0.58 (1.06–3.32)
(p< 0.001 compared to Rest1) and 1.28±0.22 (1.08–1.98) (NS compared to Rest1)
during Physio and Rest2, respectively. During cough, EE was 2.66±1.17 (1.12–
5.11) and was signiﬁcantly correlated to EE during Physio [r = 0.62 (p = 0.003)].
Conclusion: This study conﬁrms that resting EE in CF patients is increased. The
energy cost of a session of physiotherapy is highly dependent on the intensity of
cough.
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Background: Maximal cardiopulmonary exercise testing (CPET) is the most
precise method for evaluating physical function of patients with mild-to-moderate
cystic ﬁbrosis (CF). This study sought to establish the between trial variation of
CPET parameters across three different time points.
Methods: Fourteen 7−18 year olds (10 male) completed an incremental ramp cycle
test to exhaustion. Peak oxygen uptake (V˙O2peak), power output (Wpeak), heart rate
(HRpeak) and end-exercise oxygen saturation (SaO2%) and breathlessness (RPD)
were determined. Following 15-min recovery supramaximal exercise to exhaustion
was performed at a work rate (WR) equal to 110% ramp Wpeak (T1). Testing was
repeated 48 h (T2) and 4−6 weeks later (T3). Intra-class retest correlations, change
in the mean score [V˙O2peak] and the typical error for all measurements assessed
reliability.
Results: Intra-class correlations ranged from r = 0.57–0.99 and were highest for
WR. No signiﬁcant differences in mean (SD) V˙O2peak were found between T1-T2;
1.91 (0.80) and 1.93 (0.66) L×min−1, p = 0.79; T2-T3 1.81 (0.48) and 1.68 (0.50)
L×min−1, n = 13, p = 0.20 and T1-T3 1.77 (0.63) and 1.68 (0.50) L×min−1, n = 13,
p = 0.25, respectively. The highest typical error for HRpeak (T1-T2), WR (T2-T3),
RPD (T1-T2), SaO2% (T2-T3), and V˙O2peak (T1-T2) were 12, 9.3, 1.4, 1.3 and
0.3%, respectively.
Conclusion: CPET derived variables especially V˙O2peak are highly reproducible
between 1 and 42 days. Clinicians can have conﬁdence in precisely reproducing
the effect of exercise/pharmacological interventions or CF disease on parameters
obtained during CPET.
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WS16.3 The 6-Minute Walk Test in the follow-up of CF lung transplant
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C. Cazzarolli1, C. Tartali1, G. Tridello1, U. Pradal1, M. Sanguanini1, B.M. Assael1.
1Azienda Ospedaliera Universitaria Integrata Verona, Cystic Fibrosis Centre,
Verona, Italy
Background: The Six-Minute Walk Test (6MWT) is the most widely used ﬁeld
test in CF. The walked distance (6MWD) is considered a guide to assessment for
lung transplantation (LT). Moreover in clinical practice, 6MWD is undertaken to
determine the positive effects of LT, even if no studies determined its reliability in
CF LT recipients yet.
Aims: To determine the evolution of exercise performance and its relationship with
clinical status and chronic rejection (CR) in CF LT recipients.
Methods: 15 CF patients (6M, 12−43 yrs) who underwent LT were recruited.
Clinical status was evaluated by spirometry and BMI. Exercise performance was
assessed by 6MWD. CR was classiﬁed as the presence of bronchiolitis obliterans
syndrome according to the International Society for Heart and Lung Transplant
classiﬁcation. Data were collected every year after LT for 4 years.
Results: 6MWD did not change signiﬁcantly in the 4 years following LT. There
was no signiﬁcant correlation between 6MWD and FEV1%pred (r = 0.49, P = 0.07),
FEF25−75%pred (r = 0.29, P = 0.29) and BMI (r = 0.29, P = 0.29). Chronic rejection
occurred in 3 subjects, in whom the 6MWD did not change signiﬁcantly.
Conclusions: In our study the 6MWD did not signiﬁcantly change over time
despite the change of pulmonary function and nutritional status. These results
may be justiﬁed by the submaximal and self paced nature of the test. 6MWD
can be inﬂuenced also by motivation and deconditioning as well as extrapulmonary
complications. A more complete exercise evaluation, e.g. cardiopulmonary exercise
testing, could provide more useful information on the changing exercise capacity
in CF LT recipients.
WS16.4 The relationship between lung function and Modiﬁed Shuttle
Test performance in adult patients with cystic ﬁbrosis
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Objectives: Measuring exercise capacity is widely accepted as an instrument in
predicting prognosis and in evaluating treatment of patients with Cystic Fibrosis
(CF). Exercise capacity, measured as peak oxygen uptake (VO2peak) is not only a
determinant of well-being but also of survival in patients with CF. A functional
approach to measure exercise capacity is to use an instrument that closely relates
to activities in everyday life. The Modiﬁed Shuttle Test (MST) is an ofﬁce-based
walk/run test for adults with CF with proven reliability, validity and responsiveness
in this patient group.
It is assumed that the pulmonary system has approximately 30% overcapacity, and
that a small decrease in lung function does not lead to functional loss. Larger
impairments do lead to an impaired oxygen transport during exercise and hence a
loss in the capacity to perform exercise.
Aim: The aim of this study is to investigate the relationship between lung function
(FEV1) and exercise capacity in adults with moderate to severe CF.
Methods: The study sample consisted of 128 patients (61 male; mean age 25 years,
range 17−52 and FEV1 56%, range 15–124).
Conclusions: A strong statistically signiﬁcant relationship in men (r = 7.37) as well
as women (r = 0.786), between the FEV1% and the MST distance was found in the
section where FEV1 <67%. That’s where the curve shows an obvious bend, above
witch no correlation was observed between FEV1 and MST distance.
This study shows that the relationship between lung function (FEV1%), and exercise
capacity, exists only when the FEV1 <67% of predicted. These ﬁndings support
the assumption that the pulmonary system has an overcapacity of about 25−30%.
